{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:04:11Z","timestamp":1793793851133,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008262","name":"Harboe Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010983","name":"Health Research Foundation of Central Denmark Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ajog.2024.01.029","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T16:22:14Z","timestamp":1707322934000},"page":"655.e1-655.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2"],"prefix":"10.1016","volume":"230","author":[{"given":"Rikke Kamp","family":"Damgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurits","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miekel","family":"van de Sandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine Dyhr","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Kahlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti E.","family":"Gravitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim G.V.","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Steiniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone Kjeld","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-9827","authenticated-orcid":false,"given":"Anne","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.01.029_bib1","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2024.01.029_bib2","first-page":"CD012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"11","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2024.01.029_bib3","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2024.01.029_bib4","doi-asserted-by":"crossref","first-page":"656.e1","DOI":"10.1016\/j.ajog.2023.08.008","article-title":"Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study","volume":"229","author":"Lycke","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.01.029_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/aogs.14354","article-title":"I\u00a0feel reassured, but there is no guarantee.\u201d How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade 2? A qualitative study","volume":"101","author":"Hansen","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2024.01.029_bib6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/ijc.31883","article-title":"Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types","volume":"144","author":"Sand","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2024.01.029_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2018.12.024","article-title":"Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, \u226525 years of age, with NILM cytology","volume":"153","author":"Stoler","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2024.01.029_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100293","article-title":"A\u00a0study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs","volume":"22","author":"Demarco","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajog.2024.01.029_bib9","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41416-020-0790-1","article-title":"Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening","volume":"122","author":"Hashim","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2024.01.029_bib10","doi-asserted-by":"crossref","first-page":"742.e1","DOI":"10.1016\/j.ajog.2022.06.051","article-title":"Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2\u2014a prospective clinical multicenter cohort study","volume":"227","author":"Kyleb\u00e4ck","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.01.029_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cam4.1926","article-title":"Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older-a national cohort study","volume":"8","author":"Hammer","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ajog.2024.01.029_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/0284186X.2017.1355110","article-title":"Cervical screening in Denmark \u2013 a success followed by stagnation","volume":"57","author":"Lynge","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ajog.2024.01.029_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059593","article-title":"Performance of HPV E4 and p16INK4a biomarkers in predicting regression of cervical intraepithelial neoplasia grade 2 (CIN2): protocol for a historical cohort study","volume":"12","author":"Damgaard","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2024.01.029_bib16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/aogs.14627","article-title":"High prevalence of HPV16 and high-grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2","volume":"102","author":"Damgaard","year":"2023","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2024.01.029_bib17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/JCM.02831-12","article-title":"A\u00a0human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay","volume":"51","author":"van Alewijk","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ajog.2024.01.029_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jviromet.2015.01.001","article-title":"The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra","volume":"215\u2013216","author":"Geraets","year":"2015","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.ajog.2024.01.029_bib19","unstructured":"Cervical cancer screening. IARC, Handbooks of Cancer Prevention. Available at: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Handbooks-Of-Cancer-Prevention\/Cervical-Cancer-Screening-2022. Accessed February 20, 2024."},{"key":"10.1016\/j.ajog.2024.01.029_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajog.2024.01.029_bib21","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.1158\/0008-5472.CAN-10-1188","article-title":"Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study","volume":"70","author":"Wentzensen","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2024.01.029_bib22","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/ijc.24528","article-title":"Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants","volume":"125","author":"Wentzensen","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2024.01.029_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ygyno.2021.06.019","article-title":"Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: cytology and HPV genotyping","volume":"162","author":"Salvad\u00f3","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2024.01.029_bib24","unstructured":"Sweden NBoH. Cancer centrum, v\u00e5rdprogram\/cervical cancer prevention, examination of dysplasia. Available at: https:\/\/kunskapsbanken.cancercentrum.se\/diagnoser\/livmoderhalscancerprevention\/vardprogram\/handlaggning-efter-utredning-som-visar-dysplasi\/. Accessed February 20, 2024."},{"key":"10.1016\/j.ajog.2024.01.029_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/AOG.0000000000004705","article-title":"Known benefits and unknown risks of active surveillance of cervical intraepithelial neoplasia grade 2","volume":"139","author":"Lycke","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.01.029_bib26","doi-asserted-by":"crossref","unstructured":"Krog L, Lycke KD, Kahlert J, Jensen PT, Rositch AF, Hammer A. Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study. Am J Obstet Gynecol 2023. https:\/\/doi.org\/10.1016\/j.ajog.2023.11.1235.","DOI":"10.1016\/j.ajog.2023.11.1235"},{"key":"10.1016\/j.ajog.2024.01.029_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","article-title":"The natural history of cervical intraepithelial neoplasia Grades 1, 2, and 3: a systematic review and meta-analysis","volume":"25","author":"Loopik","year":"2021","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ajog.2024.01.029_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/1471-0528.16395","article-title":"The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review","volume":"128","author":"Kremer","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2024.01.029_bib29","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/cid\/ciz677","article-title":"Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia","volume":"70","author":"Louvanto","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2024.01.029_bib30","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/cam4.2855","article-title":"Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions","volume":"9","author":"Leeman","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.ajog.2024.01.029_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/path.3970","article-title":"One virus, one lesion\u2014individual components of CIN lesions contain a specific HPV type","volume":"227","author":"Quint","year":"2012","journal-title":"J\u00a0Pathol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824000723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824000723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:17:53Z","timestamp":1716801473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824000723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0002937824000723"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.01.029","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}